Peñaherrera Ernesto, Ramírez Maria, Peñaherrera Rubén, Duarte Yan C, Cáceres Silvia, Avila Elisa, Jarrin Estefania, Ullauri Vladimir, Aucancela Hugo, Bayas Miguel, Oña Freddy, Arteaga Fabricio, Ruales Jose, Liendo Kisbel, Avila Jessenia Bravo, Hidalgo Eric, Clarke Jonathan, Poulter Neil R, Beaney Thomas
Hospital Luis Vernaza, Guayaquil, Loja 700 y Escobedo, Guayaquil 090306, Ecuador.
Sociedad Ecuatoriana de Cardiologia-Nucleo Guayas, Av Francisco de Orellana, Edificio World Trade Center Torre A 4to piso of 5, Guayaquil, Ecuador.
Eur Heart J Suppl. 2021 May 20;23(Suppl B):B55-B58. doi: 10.1093/eurheartj/suab057. eCollection 2021 May.
Arterial hypertension is a growing burden worldwide, leading to over 10.8 million deaths each year. In Ecuador, it is the main risk factor for the major cause of death, coronary, and cerebrovascular disease [GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1923-1994]. The May Measurement Month Campaign in 2019 (MMM19) is a global initiative of the International Society of Hypertension aimed at raising awareness of high blood pressure (BP) and to act as a temporary solution to the lack of screening programs worldwide. A volunteer cross-sectional survey was carried out in May 2019 across 42 health centres in Ecuador. The average age was 51 (SD ±17.6) years. Blood pressure measurement, the definition of hypertension (mean of the second and third BP measurement ≥140/90 mmHg or who were medicated for high BP), and statistical analysis followed the standard MMM protocol. In total, 15 885 volunteers participated in MMM19. After multiple imputation, 6654 (41.9%) had hypertension. Of individuals not receiving antihypertensive medication, 2383 (20.5%) were hypertensive. Of individuals receiving antihypertensive medication, 1004 (23.5%) had uncontrolled BP. May Measurement Month 2019 was the largest BP screening campaign done in Ecuador. In the survey, including 6654 participants with hypertension, only 49.1% had their BP values controlled (<140/90 mmHg). May Measurement Month 2019 demonstrated a high prevalence of hypertension among volunteer screenees in our country. The high percentage of persons untreated or with uncontrolled hypertension while on pharmacologic treatment suggest that appropriate screening can help to identify a significant number of people with high BP. These data should attract the attention of health care providers and the healthcare system in Ecuador.
动脉高血压在全球范围内的负担日益加重,每年导致超过1080万人死亡。在厄瓜多尔,它是导致主要死因(冠心病和脑血管疾病)的主要风险因素[《全球疾病负担研究2017年风险因素协作组。1990 - 2017年195个国家和地区84种行为、环境、职业及代谢风险或风险群组的全球、区域和国家比较风险评估:全球疾病负担研究2017年的系统分析》。《柳叶刀》2018年;392卷:1923 - 1994页]。2019年5月测量月活动(MMM19)是国际高血压学会发起的一项全球倡议,旨在提高对高血压的认识,并作为全球筛查项目不足的临时解决方案。2019年5月在厄瓜多尔的42个健康中心开展了一项志愿者横断面调查。平均年龄为51(标准差±17.6)岁。血压测量、高血压的定义(第二次和第三次血压测量的平均值≥140/90 mmHg或正在接受高血压治疗者)以及统计分析均遵循标准的MMM方案。共有15885名志愿者参与了MMM19。经过多次插补后,6654人(41.9%)患有高血压。在未接受抗高血压药物治疗的个体中,2383人(20.5%)患有高血压。在接受抗高血压药物治疗的个体中,1004人(23.5%)血压未得到控制。2019年5月测量月是厄瓜多尔开展的规模最大的血压筛查活动。在该调查中,包括6654名高血压参与者,只有49.1%的人的血压值得到控制(<140/90 mmHg)。2019年5月测量月表明我国志愿者筛查对象中高血压患病率很高。未接受治疗或在接受药物治疗时血压未得到控制的人群比例很高,这表明适当的筛查有助于识别大量高血压患者。这些数据应引起厄瓜多尔医疗服务提供者和医疗系统的关注。